Barr Ellison Solicitors – commercial property
Advertisement: Simpsons Creative
Advertisement: partnersand mid banner
Advertisement: Cambridge Network mid banner
Advertisement: CJBS mid banner
Advertisement: Excalibur Healthcare mid banner
Mid banner advertisement: BDO
Advertisement: EBCam mid banner
Advertisement: RSM mid banner
Advertisement: Mogrify mid banner
Advertisement: Kao Data Centre mid banner
Advertisement: HCR Hewitsons recruitment mid banner
Advertisement mid banner S-Tech 1
ARM Innovation Hub
19 November, 2021 - 13:49 By Tony Quested

Endomag hiring big after Cambridge Science Park switch

Cambridge-based Endomag, whose technology is revolutionising global treatment of breast cancer, is set to increase headcount by 60 per cent by the end of next year.

CEO Eric Mayes told Business Weekly that a fresh surge of activity was underway following the success in securing 20,386 sq ft of space at 330 Cambridge Science Park for a new UK headquarters.

Dr Mayes disclosed: “Everything has advanced and evolved at Endomag. We're now in more than 43 countries and have treated over 160,000 patients. And that's just the original product portfolio.

“We've now got 75 people and expect to be around 120 by the end of next year. Our revenue growth has been particularly strong; in short, it's a really exciting time at Endomag.”

Advised by Carter Jonas, Endomag has agreed a 10-year lease at Cambridge Science Park.

Endomag creates products for use in breast cancer surgery to ensure better outcomes for patients internationally. Many of the world’s leading physicians and hospitals now use the company’s technologies. 

These comprise the Sentimag® localisation platform, a small magnetic seed marker called Magseed® and the Magtrace® lymphatic tracer – all of which are used to precisely guide removal of cancerous tissue.

The company is set to launch a series of new ground-breaking products in 2022.

Sebastian Denby, Commercial, Carter Jonas said: “The Endomag team are leaders in their field, developing technologies that have helped to create completely new surgical techniques and transform cancer care. Their new space must support their ambitions as they rapidly scale up their operations and drive innovation and it has been great to work with the team in their search for the best location. 

“Cambridge is one of the world’s leading technology hotspots and Cambridge Science Park continues to play a pivotal role in bringing together and supporting the region’s brightest and best talent. It is an ideal place for Endomag to be based and progress their cutting-edge technologies.”

Dr Mayes added: “With the rapid growth in scale, personnel and ambition of Endomag, it became clear that we needed a new, larger working space to enable our highly skilled team to continue developing world-leading products that support patients undergoing breast cancer treatment.

“This move to the Cambridge Science Park provides us with significant logistical benefits, close ties to a flourishing technology community and allows us to retain our roots in Cambridge. We’re extremely pleased with the plans for our new office and the support from Carter Jonas throughout this process.”

Cambridge Science Park owner Trinity College was advised in the transaction by Bidwells.

Newsletter Subscription

Stay informed of the latest news and features